Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1997 1
1998 2
2002 1
2004 1
2005 2
2006 2
2007 1
2008 3
2009 2
2010 2
2012 3
2013 4
2014 9
2015 6
2016 8
2017 8
2018 9
2019 7
2020 11
2021 4
2022 10
2023 12
2024 6

Text availability

Article attribute

Article type

Publication date

Search Results

104 results

Results by year

Filters applied: . Clear all
Page 1
Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial.
Gerstein HC, Colhoun HM, Dagenais GR, Diaz R, Lakshmanan M, Pais P, Probstfield J, Riesmeyer JS, Riddle MC, Rydén L, Xavier D, Atisso CM, Dyal L, Hall S, Rao-Melacini P, Wong G, Avezum A, Basile J, Chung N, Conget I, Cushman WC, Franek E, Hancu N, Hanefeld M, Holt S, Jansky P, Keltai M, Lanas F, Leiter LA, Lopez-Jaramillo P, Cardona Munoz EG, Pirags V, Pogosova N, Raubenheimer PJ, Shaw JE, Sheu WH, Temelkova-Kurktschiev T; REWIND Investigators. Gerstein HC, et al. Among authors: cardona munoz eg. Lancet. 2019 Jul 13;394(10193):121-130. doi: 10.1016/S0140-6736(19)31149-3. Epub 2019 Jun 9. Lancet. 2019. PMID: 31189511 Clinical Trial.
Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial.
Gerstein HC, Colhoun HM, Dagenais GR, Diaz R, Lakshmanan M, Pais P, Probstfield J, Botros FT, Riddle MC, Rydén L, Xavier D, Atisso CM, Dyal L, Hall S, Rao-Melacini P, Wong G, Avezum A, Basile J, Chung N, Conget I, Cushman WC, Franek E, Hancu N, Hanefeld M, Holt S, Jansky P, Keltai M, Lanas F, Leiter LA, Lopez-Jaramillo P, Cardona Munoz EG, Pirags V, Pogosova N, Raubenheimer PJ, Shaw JE, Sheu WH, Temelkova-Kurktschiev T; REWIND Investigators. Gerstein HC, et al. Among authors: cardona munoz eg. Lancet. 2019 Jul 13;394(10193):131-138. doi: 10.1016/S0140-6736(19)31150-X. Epub 2019 Jun 9. Lancet. 2019. PMID: 31189509 Clinical Trial.
Antiphospholipid Antibodies and Lipids in Hematological Malignancies.
Barreno-Rocha SG, Guzmán-Silahua S, Rodríguez-Dávila SD, Gavilanez-Chávez GE, Cardona-Muñoz EG, Riebeling-Navarro C, Rubio-Jurado B, Nava-Zavala AH. Barreno-Rocha SG, et al. Among authors: cardona munoz eg. Int J Mol Sci. 2022 Apr 8;23(8):4151. doi: 10.3390/ijms23084151. Int J Mol Sci. 2022. PMID: 35456969 Free PMC article. Review.
Blood pressure telemonitoring and telemedicine, a Latin America perspective.
Piskorz D, Alcocer L, López Santi R, Puente Barragán A, Múnera A, Molina DI, Galván Oseguera H, Barroso WS, Palomo S, Díaz-Díaz E, Cardona-Muñoz E, Wyss F, Ponte Negretti C, Rosas Peralta M, Chávez Mendoza A, Alvares López H, Patiño EP, Guerra López A, Escudero X, Enciso JM; Writing Group of Mexico Hypertension Experts Group, Interamerican Society of Hypertension, Epidemiology and Cardiovascular Prevention Council of the Interamerican Society of Cardiology, and National Cardiologist Association of Mexico. Piskorz D, et al. Among authors: cardona munoz e. Blood Press. 2023 Dec;32(1):2251586. doi: 10.1080/08037051.2023.2251586. Blood Press. 2023. PMID: 37635629 Review.
Frequency of Autoantibodies on Non-Hodgkin Lymphoma.
Barreno-Rocha SG, Guzmán-Silahua S, Cardona-Muñoz EG, Zavala-Cerna MG, Muñoz Gaytan DE, Riebeling-Navarro C, Rubio-Jurado B, Nava-Zavala AH. Barreno-Rocha SG, et al. Among authors: cardona munoz eg. Healthcare (Basel). 2023 Aug 6;11(15):2210. doi: 10.3390/healthcare11152210. Healthcare (Basel). 2023. PMID: 37570450 Free PMC article.
The Role of the Oxidative State and Innate Immunity Mediated by TLR7 and TLR9 in Lupus Nephritis.
Echavarria R, Cardona-Muñoz EG, Ortiz-Lazareno P, Andrade-Sierra J, Gómez-Hermosillo LF, Casillas-Moreno J, Campos-Bayardo TI, Román-Rojas D, García-Sánchez A, Miranda-Díaz AG. Echavarria R, et al. Among authors: cardona munoz eg. Int J Mol Sci. 2023 Oct 16;24(20):15234. doi: 10.3390/ijms242015234. Int J Mol Sci. 2023. PMID: 37894915 Free PMC article. Review.
Alternative Interventions to Prevent Oxidative Damage following Ischemia/Reperfusion.
Rodríguez-Lara SQ, Cardona-Muñoz EG, Ramírez-Lizardo EJ, Totsuka-Sutto SE, Castillo-Romero A, García-Cobián TA, García-Benavides L. Rodríguez-Lara SQ, et al. Among authors: cardona munoz eg. Oxid Med Cell Longev. 2016;2016:7190943. doi: 10.1155/2016/7190943. Epub 2016 Dec 28. Oxid Med Cell Longev. 2016. PMID: 28116037 Free PMC article. Review.
Association of the STAT4 Gene rs7574865 Polymorphism with IFN-γ Levels in Patients with Systemic Lupus Erythematosus.
Esparza Guerrero Y, Vazquez Villegas ML, Nava Valdivia CA, Ponce Guarneros JM, Perez Guerrero EE, Gomez Ramirez EE, Ramirez Villafaña M, Contreras Haro B, Martinez Hernandez A, Cardona Muñoz EG, Nuño Arana I, Gallardo Moya SG, Celis A, Gonzalez Lopez L, Gamez Nava JI, Saldaña Cruz AM. Esparza Guerrero Y, et al. Among authors: cardona munoz eg. Genes (Basel). 2023 Feb 21;14(3):537. doi: 10.3390/genes14030537. Genes (Basel). 2023. PMID: 36980810 Free PMC article.
The Role of Cardiolipin and Mitochondrial Damage in Kidney Transplant.
Miranda-Díaz AG, Cardona-Muñoz EG, Pacheco-Moisés FP. Miranda-Díaz AG, et al. Among authors: cardona munoz eg. Oxid Med Cell Longev. 2019 Nov 25;2019:3836186. doi: 10.1155/2019/3836186. eCollection 2019. Oxid Med Cell Longev. 2019. PMID: 31885786 Free PMC article. Review.
104 results